- The small animal in-vivo imaging market is seeing robust growth, primarily driven by the increasing use of advanced imaging technologies for detailed preclinical research and drug development
- The demand for non-invasive imaging techniques is growing, allowing researchers to closely observe disease progression and therapeutic effects in small animal models without the need for invasive procedures
- North America is expected to dominate the small animal (in-vivo) imaging market with share of 35.14% due to its well-established pharmaceutical and biotechnology sectors
- Asia-pacific is expected to be the fastest growing region in the small animal (in-vivo) imaging market during the forecast period with market share of 22.6% due to increasing investments in life sciences research
- The optical imaging systems segment is expected to dominate the small animal (in-vivo) imaging market with the largest share of 38.10% in 2025 due to its ability to provide high-resolution, real-time visualization of biological processes in living organisms. This technique is non-invasive and cost-effective, making it particularly suitable for longitudinal studies where repeated imaging of the same animal is required.
